MedPath

Impact of Respiratory Rehabilitation on Quality of Life in Patients With Hyperventilation Syndrome

Not Applicable
Recruiting
Conditions
Hyperventilation Syndrome
Interventions
Other: Respiratory rehabilitation
Registration Number
NCT04668638
Lead Sponsor
Centre Hospitalier Régional d'Orléans
Brief Summary

The hyperventilation syndrome is a quite frequent pathology, affecting up to 10% of the general population and 40% of the asthmatic population. Its physiopathology is still badly known and even if it is a benign affection, its associated comorbidities and symptomatology greatly decrease the patients' quality of life. Yet, no medicinal treatments have been proved useful, but prescribers noticed improvements after physiotherapy. Given that the physiotherapy impact on hyperventilation syndrome is not well described in the literature, this study aims to scientifically ascertain physiotherapy benefits on quality of life and symptomatology in hyperventilation syndrome-suffering patients.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Positive hyperventilation syndrome diagnosis
  • Having a social security insurance
  • Being at least 18 years old
  • Having given their written consent
Read More
Exclusion Criteria
  • Being put under guardianship or curatorship
  • Having seen a physiotherapist for a respiratory rehabilitation in the last three months
  • Suffering from a chronic and degenerative pathology (chronic obstructive pulmonary disease, Parkinson's disease, idiopathic fibrosis, ...)
  • Not being able to receive the respiratory rehabilitation from our care providers
  • Already having received a rehabilitation for hyperventilation syndrome
  • Not speaking French or not being unable to complete the questionnaires
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Intervention groupRespiratory rehabilitationGroup 2 (Intervention Group) will immediately receive rehabilitation between the diagnosis and the 2nd month postdiagnosis.
Control groupRespiratory rehabilitationGroup 1 (Control Group) will not immediately receive respiratory rehabilitation but between the 2nd and 4th months postdiagnosis.
Primary Outcome Measures
NameTimeMethod
Incidence of respiratory rehabilitation on Quality of lifeMonth 4

Quality of life will be evaluated with the SF-36 score

Secondary Outcome Measures
NameTimeMethod
Change in symptomatologyMonth 4

Change in symptomatology will be evaluated on the Nijmegen questionnaire

Trial Locations

Locations (1)

CHR d'Orléans

🇫🇷

Orléans, France

© Copyright 2025. All Rights Reserved by MedPath